The Accelerated Approval of Aducanumab for Treatment of Patients With Alzheimer Disease. Steinbrook R. JAMA Intern Med 2021 Jul 13. pii: 2782122. doi: 10.1001/jamainternmed.2021.4622.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Steinbrook R. The Accelerated Approval of Aducanumab for Treatment of Patients With Alzheimer Disease. JAMA Intern Med 2021 Jul 13. pii: 2782122. doi: 10.1001/jamainternmed.2021.4622.
PMID: 34254991